Scientific Intake

Scientific Intake is a health care and medical devices company founded in 2003, headquartered in the United States. The company's mission is to help consumers avoid weight-related chronic diseases and improve self-image with their patented and FDA designated non-significant risk weight management medical device, SmartByte®.

SmartByte® is designed to fill "The Treatment Gap" for consumers who either don't want or can't tolerate synthetic GLP-1 agonists or need help keeping the weight off without any side effects. Peer-reviewed research conducted at the Pennington Biomedical Research Center validated that SmartByte® users are satisfied on 23% less food than non-users, aligning with the results of new injected pharmaceutical compounds.

Scientific Intake has conducted five peer-reviewed and published clinical trials, achieving regulatory approvals in the U.S., Europe, Australia, Canada, and Brazil. Their aim is to help BMI 27-35 consumers through significant, safe weight reduction, either alone or in combination with other therapies.

The company is seeking a buyer to commercialize SmartByte and capitalize on the growth being driven by biology-based approaches to weight loss. The last investment of $2.89M in a Venture Round was made on 23 April 2018.